Insights into Joel Greenblatt (Trades, Portfolio)'s Fourth Quarter 2024 13F Filing Joel Greenblatt (Trades, Portfolio) recently submitted the 13F filing for the fourth quarter of 2024, providing insights into his investment moves during this period. Known for the invention of Magic Formula Investing, and founder of the New York Securities Auction Corporation (NYSAC), Greenblatt is founder and managing partner of Gotham Asset Management, LLC. He is the author of two investment books, including "The Little Book that Beats the Market." He is also an Adjunct Professor with Columbia Business School. Greenblatt tries to find cheap and good companies. He looks for value with a catalyst, so nice things happen sooner. Greenblatt likes special situations, and thinks that they are simply different places to find cheap stocks. In his own hedge fund, Greenblatt uses the basic principals in the Magic Formula: Look for high ROC and high earnings yield. He tries to figure out what "normalized earnings" will be 3-4 years into the future. Greenblatt makes sure the stock is very cheap based on normalized earnings. You can view the Magic Formula Stocks on the following page: Magic Formula Stocks Summary of New Buy Joel Greenblatt (Trades, Portfolio) added a total of 154 stocks, among them: The most significant addition was Talen Energy Corp (NASDAQ:TLN), with 36,437 shares, accounting for 0.07% of the portfolio and a total value of $7.34 million. The second largest addition to the portfolio was Acadia Healthcare Co Inc (NASDAQ:ACHC), consisting of 157,461 shares, representing approximately 0.06% of the portfolio, with a total value of $6.24 million. The third largest addition was Labcorp Holdings Inc (NYSE:LH), with 25,643 shares, accounting for 0.06% of the portfolio and a total value of $5.88 million. Key Position Increases Joel Greenblatt (Trades, Portfolio) also increased stakes in a total of 627 stocks, among them: The most notable increase was SPDR S&P 500 ETF Trust (SPY), with an additional 525,517 shares, bringing the total to 2,384,018 shares. This adjustment represents a significant 28.28% increase in share count, a 2.92% impact on the current portfolio, with a total value of $1,397,225,270. The second largest increase was Apple Inc (NASDAQ:AAPL), with an additional 91,141 shares, bringing the total to 620,816. This adjustment represents a significant 17.21% increase in share count, with a total value of $155,464,740. Summary of Sold Out Joel Greenblatt (Trades, Portfolio) completely exited 137 holdings in the fourth quarter of 2024, as detailed below: Story Continues Marathon Oil Corp (MRO): Joel Greenblatt (Trades, Portfolio) sold all 919,314 shares, resulting in a -0.25% impact on the portfolio. Catalent Inc (NYSE:CTLT): Joel Greenblatt (Trades, Portfolio) liquidated all 60,376 shares, causing a -0.04% impact on the portfolio. Key Position Reduces Joel Greenblatt (Trades, Portfolio) also reduced positions in 587 stocks. The most significant changes include: Reduced NVIDIA Corp (NASDAQ:NVDA) by 175,964 shares, resulting in an -8.03% decrease in shares and a -0.22% impact on the portfolio. The stock traded at an average price of $138.16 during the quarter and has returned -5.19% over the past 3 months and 3.61% year-to-date. Reduced Devon Energy Corp (NYSE:DVN) by 464,293 shares, resulting in a -91.82% reduction in shares and a -0.18% impact on the portfolio. The stock traded at an average price of $37.63 during the quarter and has returned -11.56% over the past 3 months and 5.73% year-to-date. Portfolio Overview At the fourth quarter of 2024, Joel Greenblatt (Trades, Portfolio)'s portfolio included 1,421 stocks, with top holdings including 13.25% in SPDR S&P 500 ETF Trust (SPY), 4.61% in Gotham Enhanced 500 ETF (GSPY), 2.57% in NVIDIA Corp (NASDAQ:NVDA), 1.47% in Apple Inc (NASDAQ:AAPL), and 1.29% in iShares Core S&P 500 ETF (IVV). The holdings are mainly concentrated in all 11 industries: Technology, Industrials, Consumer Cyclical, Healthcare, Financial Services, Consumer Defensive, Communication Services, Energy, Basic Materials, Real Estate, and Utilities. This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein. This article first appeared on GuruFocus. View Comments
Joel Greenblatt's Strategic Moves: SPDR S&P 500 ETF Trust Takes Center Stage with 2. ...
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...